The company is a global leader in a the highly profitable and in-demand specialty of stakeholder engagement/patient advocacy services to biopharmaceutical and medical device industry clients. For the past 20 years, the company has been providing its clients with comprehensive solutions, including public relations, market shaping, clinical trial support, public policy advocacy, social media, risk management, and overall strategic business consulting.

Key Aspects

Average pre-tax income margins of 15.9% from 2017 through 2021
Highly skilled personnel with intimate knowledge of the biopharmaceutical & medical device industries, and government processes & regulations
Over 22 years in operation, with an industry reputation for excellence and success in comprehensive stakeholder engagement

Opportunities

Capitalize on existing opportunities within the biopharmaceutical industry abroad, and further expand services across the healthcare spectrum
Expand this company’s proven and scalable model into numerous other global industries requiring comprehensive stakeholder engagement services
Leverage the company’s expertise in rare diseases to capitalize on projected growth in this area
Implement a strategic marketing campaign, including expansion of the company’s social media footprint, to grow market share and expand into other industries
Begin sourcing new projects through Federal requests-for-proposals (RFP)

Headquartered

United States

Current Markets

The company primarily services commercial customers in the biopharmaceutical and medical device industries, located across the globe.

Real Estate

The company’s operations are fully remote, with no office space leased or owned by the company.

Shareholder Objectives

The company is owned by two shareholders, with one holding a majority position. Both individuals believe it is time to transition to new ownership for their eventual retirement; however, both shareholders are willing to stay with the company for a period of time following the sale to ensure successful transition

Benchmark International

Benchmarks Exclusive Opportunities

Global Communications & Stakeholder Relations Firm – BN000038384

Global Communications & Stakeholder Relations Firm – BN000038384

Login